Free Trial

Envista Q2 2023 Earnings Report

Envista logo
$19.83 +0.64 (+3.32%)
As of 01/17/2025 03:59 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Envista EPS Results

Actual EPS
$0.43
Consensus EPS
$0.41
Beat/Miss
Beat by +$0.02
One Year Ago EPS
$0.48

Envista Revenue Results

Actual Revenue
$662.40 million
Expected Revenue
$655.81 million
Beat/Miss
Beat by +$6.59 million
YoY Revenue Growth
+2.60%

Envista Announcement Details

Quarter
Q2 2023
Time
After Market Closes

Conference Call Resources

Envista Earnings Headlines

Wells Fargo Sticks to Their Hold Rating for Envista Holdings (NVST)
Grab This Altcoin Before Trump's Crypto Announcement
Grab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which is why I'm recommending ONE coin to all investors right now.
Envista Schedules Fourth Quarter 2024 Earnings Call
See More Envista Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Envista? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Envista and other key companies, straight to your email.

About Envista

Envista (NYSE:NVST), together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products. This segment also provides software packages, which include DTX Studio Implant; DTX Studio Lab; and DTX Studio Clinic, a software package offered with its imaging products. It offers its products under the Nobel Biocare, Alpha-Bio Tec, Implant Direct, Nobel Procera, Ormco, Spark, Orascoptic, Damon, Insignia, AOA brands. The Equipment & Consumables segment provides dental equipment and supplies, including digital imaging systems, software, and other visualization/magnification systems; endodontic systems and related products; restorative materials, rotary burs, impression materials, bonding agents, and cements; and infection prevention products. This segment offers its products under the Dexis, DTX Studio, Kerr, Metrex, Total Care, Pentron, Optibond, Harmonize, Sonicfill, Sybron Endo, and CaviWipes to dental offices, clinics, and hospitals. Envista Holdings Corporation was incorporated in 2018 and is headquartered in Brea, California.

View Envista Profile

More Earnings Resources from MarketBeat